TABLE 3.
REP-PCR pattern, detection of the CTX-M-14 gene and RFLP of the plasmids of the transconjugants of the clinical strains used in this study
| Isolate no. | pI | REP-PCR pattern | PCR CTX-M-14 | Transconjugant plasmid RFLP pattern |
|---|---|---|---|---|
| 1 | 5.4, 8.0 | 1 | + | I |
| 2 | 8.0 | 2 | + | II |
| 3 | 8.0 | 3 | + | III |
| 4 | 5.4, 8.0 | 3 | + | I |
| 5 | 5.4, 8.0 | 4 | + | I |
| 6 | 5.4, 8.0 | 5 | + | IV |
| 7 | 8.0 | 6 | + | I |
| 8 | 8.0 | 7 | + | V |
| 9 | 5.4, 8.0 | 8 | + | I |
| 10 | 5.4, 8.0 | 9 | + | I |
| 11 | 5.4, 8.0 | 10 | + | VI |
| 12 | 8.0 | 11 | + | I |
| 13 | 8.0 | 12 | + | I |
| 14 | 8.0 | 13 | + | I |
| 15 | 8.0 | 12 | + | VII |
| 16 | 5.4, 8.0 | 14 | + | VIII |
| 17 | 8.0 | 15 | + | IX |
| 18 | 5.4, 8.5 | NDa | − | ND |
| 19 | 5.4 | ND | − | ND |
| 20 | 5.4 | ND | − | ND |
| 21 | 5.4 | ND | − | ND |
| 22 | 9.0 | ND | − | ND |
| 23 | 9.0 | ND | − | ND |
| 24 | 9.0 | ND | − | ND |
| 25 | 5.9 | ND | − | ND |
| 26 | 5.4, 5.9 | ND | − | ND |
| 27 | 7.6 | ND | − | ND |
| 28 | 7.4 | ND | − | ND |
| 29 | 7.9 | ND | − | ND |
| 30 | 7.4 | ND | − | ND |
a
ND, not done.